HTG Molecular Diagnostics CEO John Lubniewski's 2021 pay falls 49% to $737K

HTG Molecular Diagnostics reports 2021 executive compensation

By ExecPay News

Published: July 7, 2022

HTG Molecular Diagnostics reported fiscal year 2021 executive compensation information on July 7, 2022.
In 2021, three executives at HTG Molecular Diagnostics received on average a compensation package of $563K, a 39% decrease compared to previous year.
Average pay of disclosed executives at HTG Molecular Diagnostics
John L. Lubniewski, Chief Executive Officer, received $737K in total, which decreased by 49% compared to 2020. 62% of Lubniewski's compensation, or $460K, was in salary. Lubniewski also received $276K in non-equity incentive plan and $741 in other compensation.
Shaun D. McMeans, Chief Financial Officer, received a compensation package of $511K, which decreased by 36% compared to previous year. 72% of the compensation package, or $370K, was in salary.
Byron T. Lawson, Chief Commercial Officer, earned $440K in 2021, a 17% decrease compared to previous year.

Related executives

John Lubniewski

HTG Molecular Diagnostics

Chief Executive Officer

Shaun McMeans

HTG Molecular Diagnostics

Chief Financial Officer

Byron Lawson

HTG Molecular Diagnostics

Chief Commercial Officer

You may also like

Source: SEC filing on July 7, 2022.